Maini, R., Taylor, P., Szechinski, J., Pavelka, K., Broll, J., Balint, G., . . . Kishimoto, T. (2008). Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006).
Chicago Style (17th ed.) CitationMaini, R., et al. Double-blind Randomized Controlled Clinical-trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients with Rheumatoid Arthritis Who Had an Incomplete Response to Methotrexate (vol 54, Pg 2817, 2006). 2008.
MLA引文Maini, R., et al. Double-blind Randomized Controlled Clinical-trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients with Rheumatoid Arthritis Who Had an Incomplete Response to Methotrexate (vol 54, Pg 2817, 2006). 2008.